EMA publishes updated VeDDRA terms, proposed new guidance for Phase II ERA and updated eSubmission guidance

The EMA has published a number of new and updated guidance documents:

• Updates to the VeDDRA clinical terms following the annual review (Link)
• Concept paper on the testing strategy and risk assessment for plants in the Phase II of the ERA for VMPs (Link)
• Updated guidance on eSubmission (Link)